This Week in PLOS

A PLOS One study by Swiss researchers suggests individuals may have distinct and distinguishable metabolite profiles in their breath. The research team used real-time mass spectrometry to assess exhaled compounds in breath samples from six men and five women. Analyses of the samples — taken at multiple times per day for each individual over nine days — revealed consistent core metabolite "breathprints" that were specific to each individual and remained stable over time.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.